Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$8M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 21 most recent Form 4 transactions.
| $241.9K |
| -0.9% |
| Open the original filing on SEC.gov |
| Sep 14 | RYTM | Rhythm Pharmaceuticals,… | SSELL◷ | 1,817 | $104.55 | $190K | -0.8% | Open the original filing on SEC.gov |
| Sep 14 | RYTM | Rhythm Pharmaceuticals,… | SSELL◷ | 8,698 | $103.43 | $899.6K | -3.5% | Open the original filing on SEC.gov |
| Sep 14 | RYTM | Rhythm Pharmaceuticals,… | SSELL◷ | 30,746 | $102.35 | $3.1M | -10.9% | Open the original filing on SEC.gov |
| Sep 14 | RYTM | Rhythm Pharmaceuticals,… | SSELL◷ | 6,439 | $101.75 | $655.1K | -2.2% | Open the original filing on SEC.gov |
| Sep 14 | RYTM | Rhythm Pharmaceuticals,… | MEXER◷ | 50,000 | $6.05 | $302.5K | +20.9% | Open the original filing on SEC.gov |
| Jun 17 | KARD | Kardigan, Inc. | AGRANT | 20,706 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | TRVI | Trevi Therapeutics, Inc. | AGRANT◆ | 35,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 11 | RYTM | Rhythm Pharmaceuticals,… | AGRANT◆ | 107,850 | — | — | — | Open the original filing on SEC.gov |
| Feb 11 | RYTM | Rhythm Pharmaceuticals,… | AGRANT◆ | 71,900 | — | — | — | Open the original filing on SEC.gov |
| Feb 1 | RYTM | Rhythm Pharmaceuticals,… | MEXER◆ | 33,338 | — | — | — | Open the original filing on SEC.gov |
| Feb 1 | RYTM | Rhythm Pharmaceuticals,… | MEXER◆ | 21,250 | — | — | — | Open the original filing on SEC.gov |
| Feb 1 | RYTM | Rhythm Pharmaceuticals,… | MEXER◆ | 14,125 | — | — | — | Open the original filing on SEC.gov |
| Feb 1 | RYTM | Rhythm Pharmaceuticals,… | FTAX | 31,522 | $108.99 | $3.4M | -11.7% | Open the original filing on SEC.gov |
| Feb 1 | RYTM | Rhythm Pharmaceuticals,… | MEXER | 68,713 | — | — | +34.1% | Open the original filing on SEC.gov |
| Jun 11, 2025 | TRVI | Trevi Therapeutics, Inc. | AGRANT◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 3, 2025 | RYTM | Rhythm Pharmaceuticals,… | MEXER◷◆ | 43,620 | — | — | — | Open the original filing on SEC.gov |
| Jun 3, 2025 | RYTM | Rhythm Pharmaceuticals,… | SSELL◷ | 274 | $65.60 | $18K | -0.1% | Open the original filing on SEC.gov |
| Jun 3, 2025 | RYTM | Rhythm Pharmaceuticals,… | SSELL◷ | 43,346 | $65.04 | $2.8M | -17.7% | Open the original filing on SEC.gov |
| Jun 3, 2025 | RYTM | Rhythm Pharmaceuticals,… | MEXER◷ | 43,620 | $4.59 | $200.2K | +21.6% | Open the original filing on SEC.gov |